Mylan rebrands Dey Pharma unit

PITTSBURGH — Mylan is changing the name of its branded specialty pharmaceutical business, the company said Wednesday.



The drug maker announced that it would change the name of Dey Pharma to Mylan Specialty. Dey makes treatments for respiratory diseases, psychiatric disorders and severe allergic reactions, including the EpiPen (epinephrine).



The rebranding of the subsidiary comes just months after a similar change to the name of another subsidiary, Matrix Labs, whose name the company changed to Mylan Labs in 2006. Mylan acquired Hyderabad, India-based Matrix in 2006.

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.